SINPHAR — AGM Information 2024

Jul 2, 2024

Stock Code: 1734

Sinphar Pharmaceutical Co., Ltd.

Meeting Notice

for

Annual Shareholders’ Meeting

(Summary Translation)

The 2024 Annual Shareholders’ Meeting (the “Meeting”) of Sinphar Pharmaceutical Co., Ltd. (the “Company”) will be convened at 10:00 a.m., Wednesday, June 19, 2024 at Vocational Training Center. (No. 95, Xinliao Rd., Zhongshan Village, Dongshan Township, Yilan County 269, Taiwan (R.O.C.))

1. The agenda for the Meeting is as follows:

I. Company Reports

(1) 2023 Business Report

(2) Audit Committee’s Review Report on the 2023 Financial Statements

(3) Report on 2023 Remuneration Distribution for Directors and Employees

(4) Report on Amendment to the Rules and Procedures of Board of Directors Meetings

(5) Status Report of Endorsements and Guarantees for Subsidiaries

(6) Other Matters

II. Ratifications

(1) Adoption of the 2023 Business Report and Financial Statements

(2) Adoption of 2023 Earnings Distribution

III. Discussions

(1) Proposal for Issuing New Shares through Capitalization of Retained Earnings

Ⅳ. Election

(1) Election of Directors

Ⅴ. Other Proposals

(1) Proposal for Release the Prohibition on Directors from Participation in

Competitive Business

Ⅵ. Extraordinary Motions

• 1 -

Stock Code: 1734

Information of Candidates for Directors:

Name	Current Position	Education	Experience	Shareholding
Chih Wen Lee	•Director, Sinphar Pharmaceutical Co., Ltd.	• Bachelor Degree in Pharmacy, Kaohsiung Medical University (pharmacist)	• Director, Institute for Biotechnology and Medicine Industry • Chairman, Sinphar Pharmaceutical Co., Ltd.	3,149,791
Hsiu Min Lin	• Director, Sinphar Pharmaceutical Co., Ltd.	• National Ilan Institute, Agriculture and Technology	• Director, Sinphar Pharmaceutical Co., Ltd.	1,336,876
Good Tree Investment Co., Ltd. Representative: Hsiu Chi Kuo	None	Not applicable	None	919,000
Ling Mo Chao	• Chairman, Giant Goal Leather MFG. Inc. • Director, Sinphar Pharmaceutical Co., Ltd.	• Taichung Municipal Sha-Lu Industrial High School	• Chairman, Giant Goal Leather MFG. Inc. • Director, Sinphar Pharmaceutical Co., Ltd.	1,489,547
Xing-Da Capital Corp. Representative: Yi Ta Lee	• Corporate Director, Sinphar Pharmaceutical Co., Ltd.	Not applicable	• Corporate Director, Sinphar Pharmaceutical Co., Ltd.	15,729,464
Hung Chih Lin	• Director, Sinphar Pharmaceutical Co., Ltd.	•Bachelor Degree in Chemical and Materials Engineering, Chinese Culture University	• Chairman, Daxie Boutique Department Store Co., Ltd. • Chairman, Jian-Sheng Co., Ltd.	1,000,128
Jehng Jer Guan	• Director, Sinphar Pharmaceutical Co., Ltd.	• Ph.D. in Graduate Institute for Sun Yat-Sen Thoughts, Chinese Culture University	• Deputy Director-general, National Police Agency, Ministry of the Interior	0

• 2 -

Stock Code: 1734

Name	Current Position	Education	Experience	Shareholding
Neng Chun Yu	• Director, Sinphar Pharmaceutical Co., Ltd. • Superintendent, NENG-CHUN DIABETES CLINIC	• China Medical University, Taiwan	• President, Taiwanese Association of Diabetes Educators • Honorary President, Yilan Association of Diabetes Supporters	999,763

Information of Candidates for Independent Director:

Name	Current Position	Education	Experience	Shareholding
Ching Lung Lee	• Professor, National Taiwan University • Chair Professor, National Chung Hsing University • National Policy Advisor to the President • Chairman, BELX Bio-Pharmaceutical Co., Ltd. • Independent Director, Sinphar Pharmaceutical Co., Ltd. • Independent Director, VISGENEER INC • Independent Director, Tatung Company	• Ph.D. in Horticulture, Leibniz University Hannover	• Chairperson, Council of Agriculture, Executive Yuan • Chairman, Taiwan Fertilizer Co., Ltd.	0
Yau Yuan Wen	• Independent Director, Sinphar Pharmaceutical Co., Ltd. • Independent Director, AMIDA Technology, Inc.	• Master Degree in Law, National Taiwan University	• Administrative Chief Judge, Division-Chief Judge of Taiwan High Court • Chief Judge, Taiwan Miaoli District Court	0

• 3 -

Stock Code: 1734

Name	Current Position	Education	Experience	Shareholding
Hsin Yu Chou	• Independent Director, Sinphar Pharmaceutical Co., Ltd. • Accounting Manager, Nice Garden Industrial Co., Ltd.	• Bachelor Degree in Accounting, Aletheia University	• Assistant General Manager, Crowe (TW) CPAs • Senior Accounting Manager, Sabrina Fashion Industrial Corp.	0

Information of Release the Prohibition on Directors from Participation in Competitive Business:

	Company Name and Concurrent Position	Main Business Scope and Conflict of Interest
Name
Chairman, Chih Wen Lee	Chairman, SynCore Biotechnology Co., Ltd. Chairman, ZuniMed Biotech Co., Ltd. Chairman, SUNETIC BIOTECH INC Chairman, UNIVERSAL NEXT TECHNOLOGIES INC	Drugs, functional food, medical devices Similar industry, submit to permit to lift the restriction.
Vice Chairman, Yi Ta Lee	Vice Chairman, SynCore Biotechnology Co., Ltd. Chairman, ZuniMed Biotech Co., Ltd. Director, SUNETIC BIOTECH INC Chairman, CanCap Pharmaceutical Ltd. Representative, SynCore Biotechnology Europe GmbH Independent Director, Bionet Corp.	Drugs, functional food, medical devices, cell therapy, regenerative medicine, big data in healthcare Similar industry, submit to permit to lift the restriction.
Director, Hsiu Chi Kuo	Chairman, Glory Nutria Ltd. Chairman, Vit-Gute Nutrition Ltd.	Sales agency for health supplements Similar industry, submit to permit to lift the restriction.

• 4 -

Stock Code: 1734

	Company Name and Concurrent Position	Main Business Scope and Conflict of Interest
Name
Independent Director, Hsin Yu Chou	Accounting Manager, Nice Garden Industrial Co., Ltd.	Agricultural biotechnology, manufacturing and wholesale of veterinary drugs Similar industry, submit to permit to lift the restriction.
Independent Director, Ching Lung Lee	Independent Director, VISGENEER INC Chairman, BELX Bio-Pharmaceutical Co., Ltd.	Medical devices, new drug R&D, biotechnology, skincare products Similar industry, submit to permit to lift the restriction.

1. The resolution of 2023 earnings distribution passed by the Board of Directors is

2. as follows:

Cash Dividend:

The Company has proposed to distribute cash dividend to shareholders of

NT$167,722,022, which is NT$1 per share.

Stock Dividend:

The Company has proposed to distribute stock dividend to shareholders of

NT$134,177,620, which is 80 shares per thousand shares.

The Board of Directors is authorized to determine the ex-dividend date after the proposal is approved by the Meeting.

Board of Directors

Sinphar Pharmaceutical Co., Ltd.

• 5 -